和自调节器:一个治疗分离
Hayder M Al-Kuraishy1, Majid S Jabir2, Ali I Al-Gareeb3
1Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
Autophagy
|May 16, 2025
概括
自失调有助于发作. 调节细胞过程自,通过影响控制,为耐火性提供了潜在的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种神经系统疾病,以反复发作为特征,三分之一的患者患有不耐药性,对抗药物 (AED) 没有反应.
- 宏自/自是一种细胞降解过程,涉及病原体,可能通过调节神经递质平衡.
研究的目的:
- 审查自在发病 (发病) 和已确定的发病的发展和进展中的作用.
- 讨论自调节剂 (诱导剂和抑制剂) 如何影响生和.
主要方法:
- 关于自在中的作用的现有文献的小综述.
- 在和状态 (SE) 的背景下,分析研究自诱导剂和抑制剂的研究.
主要成果:
- 自似乎可以防止发作,但它在状态 (SE) 中的作用是复杂的,这表明它具有双重效应.
- 自诱导剂可能会减少发作的频率和严重程度,将它们定位为的潜在辅助疗法.
- 相反,自抑制剂已经表现出抗作用,突出显示了自的复杂参与.
结论:
- 自调节为管理提供了一个有前途的治疗途径,特别是在耐火病例中.
- 需要进一步的研究来阐明精确的机制,并优化用于治疗和SE的自调节器的使用.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
260
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
260
Antiepileptic Drugs: GABAergic Pathway Potentiators
293
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
293
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
199
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
199
Autophagy
4.1K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.1K
Antiepileptic Drugs: Potassium Channel Activators
136
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
136
Arteries of the Lower Limbs
172
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
172


